Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yunnan Baiyao Aerosol for Pain from Closed Rib Fractures
ChiCTR2600126911Phase 4Not yet recruiting
- Sponsor
- Shenzhen University General Hospital
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in rib fracture comparing Yunnan Baiyao Aerosol with Placebo aerosol (2 arms). Primary endpoint: Pain intensity difference (PID) at 90 minutes after first dose. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
Yunnan Baiyao
03
Conditions
rib fracture
Beyond the preview
Go deeper on ChiCTR2600126911.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600126911.